Hyperaldosteronism

Last updated: January 26, 2026

Hyperaldosteronism

Endocrine System

Endocrine System

Pharyngeal arches, pouches, and clefts
Endocrine system anatomy and physiology
Anatomy of the thyroid and parathyroid glands
Anatomy of the abdominal viscera: Pancreas and spleen
Pituitary gland histology
Thyroid and parathyroid gland histology
Pancreas histology
Adrenal gland histology
Synthesis of adrenocortical hormones
Adrenocorticotropic hormone
Growth hormone and somatostatin
Hunger and satiety
Antidiuretic hormone
Thyroid hormones
Insulin
Insulins
Glucagon
Somatostatin
Cortisol
Testosterone
Estrogen and progesterone
Oxytocin and prolactin
Parathyroid hormone
Calcitonin
Vitamin D
Phosphate, calcium and magnesium homeostasis
Congenital adrenal hyperplasia
Adrenal insufficiency: Pathology review
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Cushing syndrome and Cushing disease: Pathology review
Cushing syndrome
Conn syndrome
Pheochromocytoma
Adrenal masses: Pathology review
Adrenal masses and tumors: Clinical
Adrenal cortical carcinoma
Thyroglossal duct cyst
Hyperthyroidism
Hyperthyroidism: Pathology review
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Euthyroid sick syndrome
Hypothyroidism
Hypothyroidism: Pathology review
Hashimoto thyroiditis
Hypothyroidism and thyroiditis: Clinical
Subacute granulomatous thyroiditis
Riedel thyroiditis
Thyroid storm
Thyroid nodules and thyroid cancer: Pathology review
Thyroid cancer
Thyroid nodules and thyroid cancer: Clinical
Parathyroid disorders and calcium imbalance: Pathology review
Parathyroid conditions and calcium imbalance: Clinical
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes mellitus: Clinical
Diabetic nephropathy
Diabetic retinopathy
Pancreatic neuroendocrine neoplasms
Diabetes insipidus and SIADH: Pathology review
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hypopituitarism: Pathology review
Hypopituitarism
Hyperpituitarism
Pituitary adenoma
Pituitary apoplexy
Pituitary tumors: Pathology review
Sheehan syndrome
Hyperprolactinemia
Prolactinoma
Hypoprolactinemia
Gigantism
Acromegaly
Constitutional growth delay
Puberty and Tanner staging
Precocious puberty
Delayed puberty
Kallmann syndrome
Disorders of sex chromosomes: Pathology review
5-alpha-reductase deficiency
Menstrual cycle
Polycystic ovary syndrome
Premature ovarian failure
Menopause
Androgen insensitivity syndrome
Autoimmune polyglandular syndrome type 1 (NORD)
Multiple endocrine neoplasia: Pathology review
Multiple endocrine neoplasia
Carcinoid syndrome
Neuroblastoma
Opsoclonus myoclonus syndrome (NORD)
Hyperthyroidism medications
Hypothyroidism medications
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Adrenal hormone synthesis inhibitors

Transcript

Watch video only

With hyperaldosteronism, "hyper" means too much, and "aldosteronism" refers to the hormone aldosterone, which is made by the adrenal glands. So, hyperaldosteronism is a condition where the adrenal glands produce too much aldosterone.

Now, each of the two adrenal glands sits on top of a kidney and has two main parts.

The inner part, the medulla, produces the hormones epinephrine and norepinephrine.

On the flip side, the outer part, the cortex, has three layers. The innermost layer, the zona reticularis, produces androgens, such as dehydroepiandrosterone, which is a precursor of testosterone. The middle layer, the zona fasciculata, produces glucocorticoids, like cortisol. With glucocorticoids, “gluco-” refers to glucose, because they help increase blood glucose levels. The outermost layer, the zona glomerulosa, produces mineralocorticoids, such as aldosterone. With mineralocorticoids, “mineralo-” refers to minerals, because these hormones help regulate sodium and potassium levels. Now, the zona glomerulosa is controlled by the renin-angiotensin-aldosterone system.

When blood pressure or sodium levels drop, the juxtaglomerular cells in the kidneys release renin into the bloodstream. In the bloodstream, renin cleaves angiotensinogen into angiotensin I, which is later converted by angiotensin-converting enzyme or ACE, into angiotensin II.

Angiotensin II raises blood pressure through two mechanisms.

First, it triggers vasoconstriction of small arterioles, subsequently increasing peripheral vascular resistance. Second, angiotensin II stimulates the zona glomerulosa to release aldosterone.

Once in the bloodstream, aldosterone travels to the kidneys, more specifically, to the distal tubules and collecting ducts of the nephron.

Here, aldosterone squeezes into principal cells and stimulates mineralocorticoid receptors. When aldosterone activates mineralocorticoid receptors, the sodium-potassium pumps kick into high gear.
They begin to pump more sodium ions from the cell into the bloodstream.

This intracellular drop in sodium pulls more sodium from the tubule into the cell, following its concentration gradient. As sodium moves, water follows, so more water leaves the tubule and enters the blood vessels, eventually increasing blood volume and raising blood pressure.

At the same time, pumps pull potassium from the blood into the cells.

From here, potassium flows down its concentration gradient into the tubule to get excreted in the urine. That’s why another key trigger for the zona glomerulosa to release aldosterone is a high potassium level in the blood. Aldosterone helps the body remove extra potassium while holding on to sodium and water.

Now, based on the underlying pathology, hyperaldosteronism can be further subdivided into primary- and secondary types.

Primary hyperaldosteronism means that the adrenal glands are responsible for the excess production of aldosterone. The most common cause of primary hyperaldosteronism is bilateral idiopathic hyperaldosteronism. “Bilateral” means it affects both adrenal glands, and “idiopathic” means we’re not sure what’s causing it. But if we slice through the adrenal glands, we can recognize this condition by focal or widespread hyperplasia of cells that resemble those in the zona glomerulosa, which produce aldosterone.

Next, there are adrenocortical neoplasms.

Sources

  1. "Robbins & Kumar Basic Pathology. Available from: ClinicalKey Student, (11th Edition). Page 668-669 " Elsevier Limited (UK) (2022)
  2. "Robbins & Cotran Pathologic Basis of Disease. Available from: ClinicalKey Student, (10th Edition). Page 1118-1119 " Elsevier Health Sciences (US) (2020)
  3. "USMLE Step 1 Secrets in Color. Available from: ClinicalKey Student, (5th Edition). Page 174 " Elsevier Limited (UK) (2022)
  4. "Conn's Current Therapy 2024. Available from: ClinicalKey Student, Page 343-345 " Elsevier Limited (UK) (2023)
  5. "Textbook of Medical Physiology. Available from: ClinicalKey Student, (14th Edition). Page 955-962 " Elsevier Health Sciences (US) (2020)